Partner Marc Ross Represents Israeli Medical Marijuana Company OWC Pharmaceutical Research Corp. in Financing

Press Release – New York, NY – December 30, 2015 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the firm has represented OWC Pharmaceutical Research Corp. (OTCQB: OWCP) (the “Company”), a company focused on discovering, developing and commercializing cannabis-based novel therapeutics and treatments, in connection with a $37,500 convertible note and $750,000 equity purchase agreement with Kodiak Capital Group, LLC., a California-based institutional investor (“Kodiak”). The Company has agreed to file a registration statement with the SEC covering the shares issuable upon conversion of the note and the shares that may be issued to Kodiak under the terms of the agreement. After the SEC has declared the registration statement related to the transaction effective, the Company will have the right at its sole discretion to sell up to $750,000 of common stock under the terms set forth in the agreement. The Sichenzia Ross Friedman Ference LLP team was led by partners Marc Ross and James Turner and associate Avital Even-Shoshan.

Author
Recent Posts

Sichenzia Ross Ference LLP

Sichenzia Ross Ference LLP is a full service law firm with a nationally recognized corporate, securities and litigation practice that provides experienced representation in all matters involving the securities industry. In addition to handling routine to complex commercial matters, SRF’s renowned litigation department specializes in defending companies and individuals against all types of securities cases, including class action lawsuits, shareholder derivative actions, and matters involving allegations of fraud, misrepresentation or other securities violations. The litigation team has also brought defamation lawsuits against companies and individuals related to market manipulation. Additionally, it represents individuals and companies in investigations by the Securities and Exchange Commission (SEC) and other regulatory bodies. The litigation team has a robust practice representing brokers and broker-dealers in arbitrations before the Financial Industry Regulatory Authority (FINRA). These arbitrations typically involve claims of unsuitability, churning, unauthorized trading and other allegations of broker misconduct. Finally, SRF has a burgeoning expungement practice, where it represents brokers seeking to have negative and harmful customer complaints removed from their industry records. The firm complements its core practice areas with an established commercial real estate and trusts and estates practice.

Visit SRF's LinkedIn page

Latest posts by Sichenzia Ross Ference LLP (see all)

Partner Marc Ross Represents Israeli Medical Marijuana Company OWC Pharmaceutical Research Corp. in Financing

Related Posts